Physician profile
Christopher J Pope
NPI 1962529271
$1,187.04
in general payments reported to CMS, 2019-2025
18 companies · $355 in 2025
The $355 reported for 2025 was more than what 88% of Pediatrics (Nurse Practitioner) providers received nationally (typical 2025 total: $93.49).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $13.43 · 2022: $229 · 2023: $343 · 2024: $246 · 2025: $355.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $945.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $944.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $276.30 | 2023-2025 | Azstarys |
| Merck Sharp & Dohme LLC | $200.28 | 2022-2025 | Vaxneuvance, Gardasil 9, Gardasil |
| Regeneron Healthcare Solutions, INC. | $124.95 | 2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $81.98 | 2022 | |
| Sanofi-Aventis U.S. LLC | $68.38 | 2025 | |
| Sanofi Pasteur INC. | $65.24 | 2022-2025 | |
| Astrazeneca Pharmaceuticals LP | $55.59 | 2023-2024 | Flumist Quadrivalent |
| Ironshore Pharmaceuticals INC. | $51.51 | 2024 | |
| Sobi, INC | $48.39 | 2022-2023 | |
| Supernus Pharmaceuticals, INC. | $41.18 | 2021-2025 | Qelbree |
| Phadia US INC. | $36.87 | 2022-2023 | Immunocap |
| Teva Pharmaceuticals USA, INC. | $25.70 | 2022 | |
| Kyowa Kirin, INC. | $25.21 | 2024 | Crysvita |
| Ars Pharmaceuticals Operations, INC. | $24.82 | 2025 | Neffy |
| Cranial Technologies, INC | $19.60 | 2025 | Doc Band |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kowa Pharmaceuticals America, INC. | $15.47 | 2025 | Zoryve |
| Cipher Pharmaceuticals US LLC | $13.90 | 2025 | Natroba, Spinosad |
| Pfizer INC. | $11.67 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Pope listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.